Harnessing AI-Driven Digital Twins and Synthetic Data in Healthcare and Drug Discovery

Healthcare and drug discovery teams are increasingly using AI-driven digital twins plus synthetic data to simulate patient responses and speed clinical R&D. Reports cited (Crescendo AI, Forbes India) say adoption is rising, with digital twins expected to become essential by 2026. Regulators are also warming to synthetic data for privacy-preserving testing and validation.